Viktor Levitski

5 Patents

• US125655302026

  Combination Therapy with Targeted 4-1BB (CD137) Agonists/anti-fap Binding Domain and Anti-cea/anti-cd3 Bispecific Antibody

  Hoffmann-la Roche Inc.

  0 cites
• US124418122025

  Methods of Treating Cancer by Administering Tumor Necrosis Factor (TNF) Family Ligand Trimer-containing Antigen-binding Molecules

  Hoffmann-la Roche Inc.

  0 cites
• US123917572025

  Bispecific Antibodies Specific for PD1 and TIM3

  Hoffmann-la Roche Inc.

  0 cites
• US122409112025

  Bispecific Antibodies Specific for OX40

  Hoffmann-la Roche Inc.

  0 cites
• US122028702025

  Antigen Binding Molecules Comprising a Trimeric TNF Family Ligand and Encoding Polynucleotides Thereof

  Hoffmann-la Roche Inc.

  0 cites